116 related articles for article (PubMed ID: 26200390)
1. CO-Releasing Polymers Exert Antimicrobial Activity.
Nguyen D; Nguyen TK; Rice SA; Boyer C
Biomacromolecules; 2015 Sep; 16(9):2776-86. PubMed ID: 26200390
[TBL] [Abstract][Full Text] [Related]
2. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
[TBL] [Abstract][Full Text] [Related]
3. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
[TBL] [Abstract][Full Text] [Related]
4. Cationic Carbon Monoxide-Releasing Polymers as Antimicrobial and Antibiofilm Agents by the Synergetic Activity.
Wang L; Zhong W; Liu B; Pranantyo D; Chan-Park MB
ACS Appl Mater Interfaces; 2023 Sep; 15(35):41772-41782. PubMed ID: 37609827
[TBL] [Abstract][Full Text] [Related]
5. Highly branched polymers with polymyxin end groups responsive to Pseudomonas aeruginosa.
Sarker P; Shepherd J; Swindells K; Douglas I; MacNeil S; Swanson L; Rimmer S
Biomacromolecules; 2011 Jan; 12(1):1-5. PubMed ID: 21126084
[TBL] [Abstract][Full Text] [Related]
6. Needed, new paradigms in antibiotic development.
Ceri H; Olson ME; Turner RJ
Expert Opin Pharmacother; 2010 Jun; 11(8):1233-7. PubMed ID: 20384540
[TBL] [Abstract][Full Text] [Related]
7. Highly effective contact antimicrobial surfaces via polymer surface modifiers.
Kurt P; Wood L; Ohman DE; Wynne KJ
Langmuir; 2007 Apr; 23(9):4719-23. PubMed ID: 17388618
[TBL] [Abstract][Full Text] [Related]
8. Differential antibacterial activity against Pseudomonas aeruginosa by carbon monoxide-releasing molecules.
Desmard M; Foresti R; Morin D; Dagouassat M; Berdeaux A; Denamur E; Crook SH; Mann BE; Scapens D; Montravers P; Boczkowski J; Motterlini R
Antioxid Redox Signal; 2012 Jan; 16(2):153-63. PubMed ID: 21864022
[TBL] [Abstract][Full Text] [Related]
9. Review: Antibiotic discovery in the age of structural biology - a comprehensive overview with special reference to development of drugs for the treatment of Pseudomonas aeruginosa infection.
Koehnke A; Friedrich RE
In Vivo; 2015; 29(2):161-7. PubMed ID: 25792642
[TBL] [Abstract][Full Text] [Related]
10. A role for reactive oxygen species in the antibacterial properties of carbon monoxide-releasing molecules.
Tavares AF; Nobre LS; Saraiva LM
FEMS Microbiol Lett; 2012 Nov; 336(1):1-10. PubMed ID: 22774863
[TBL] [Abstract][Full Text] [Related]
11. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
[TBL] [Abstract][Full Text] [Related]
12. Effects of antibiotics on Pseudomonas aeruginosa NK125502 and Pseudomonas fluorescens MF0 biofilm formation on immobilized fibronectin.
Gagnière H; Di Martino P
J Chemother; 2004 Jun; 16(3):244-7. PubMed ID: 15330319
[TBL] [Abstract][Full Text] [Related]
13. Secondary and tertiary polydiallylammonium salts: novel polymers with high antimicrobial activity.
Timofeeva LM; Kleshcheva NA; Moroz AF; Didenko LV
Biomacromolecules; 2009 Nov; 10(11):2976-86. PubMed ID: 19795886
[TBL] [Abstract][Full Text] [Related]
14. Bacteria-Resistant Single Chain Cyclized/Knotted Polymer Coatings.
Xu Q; A S; Venet M; Gao Y; Zhou D; Wang W; Zeng M; Rotella C; Li X; Wang X; Lyu J; Rodriguez BJ; Wang W
Angew Chem Int Ed Engl; 2019 Jul; 58(31):10616-10620. PubMed ID: 31150131
[TBL] [Abstract][Full Text] [Related]
15. [Selected mechanisms of resistance to antimicrobial drugs in Pseudomonas aeruginosa and their detection].
Liptáková A; Siegfried L; Jarcuska P; Schrér I
Klin Mikrobiol Infekc Lek; 2005 Jun; 11(3):109-11. PubMed ID: 16025430
[TBL] [Abstract][Full Text] [Related]
16. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
Khan JA; Iqbal Z; Rahman SU; Farzana K; Khan A
Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
[TBL] [Abstract][Full Text] [Related]
17. MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 5: Carbon-substituted analogues at the C-2 position.
Yoshida K; Nakayama K; Kuru N; Kobayashi S; Ohtsuka M; Takemura M; Hoshino K; Kanda H; Zhang JZ; Lee VJ; Watkins WJ
Bioorg Med Chem; 2006 Mar; 14(6):1993-2004. PubMed ID: 16290941
[TBL] [Abstract][Full Text] [Related]
18. Virulence attributes in Brazilian clinical isolates of Pseudomonas aeruginosa.
Silva LV; Galdino AC; Nunes AP; dos Santos KR; Moreira BM; Cacci LC; Sodré CL; Ziccardi M; Branquinha MH; Santos AL
Int J Med Microbiol; 2014 Nov; 304(8):990-1000. PubMed ID: 25127423
[TBL] [Abstract][Full Text] [Related]
19. Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009.
Master RN; Clark RB; Karlowsky JA; Ramirez J; Bordon JM
Int J Antimicrob Agents; 2011 Oct; 38(4):291-5. PubMed ID: 21737249
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
